True for drug trials, way off for medical device trials, and way way off for diagnostic trial. no need to secure experimental drugs of high quality in small amounts, treat and follow patients, usually for years, and all those other factors that make the drug trials so infernally expensive. The Buffalo trial was 500 patients, took place in three months (!!!) and cost a total of ... I am not sure but I think the whole larger trial is 3 million? (Someone corrrect me on this.) And that is a thousand patients.
Wichita wrote:Does anyone have a link to the article that Ashton Embry is refuting, entitled "Cerebrospinal Venous Insufficiency and Multiple Sclerosis (Khan et al, 2010, Annals of Neurology)"?
Users browsing this forum: spadworld